Global Vaccine Uptake Trends

Variation in Vaccine Doses

Vaccine uptake has shown significant variation across the globe. Some countries continue to report higher rates of first COVID-19 vaccine doses compared to second doses, indicating that many individuals may be opting to skip their second dose.

Concerns About Skipping the Second Dose

Recent research suggests that forgoing the second dose of the COVID-19 vaccine may not be advisable. Traditionally, the approval process for new vaccines worldwide has been comprehensive and lengthy. From an immunological standpoint, effective vaccines must successfully trigger the production of neutralizing antibodies through specific immune cells known as B cells, which are crucial for blocking viral infections.

Understanding mRNA Vaccines

Pfizer and Moderna Vaccines

The Pfizer and Moderna vaccines operate on similar principles. They both utilize mRNA technology to provide the genetic instructions necessary for producing spike proteins of the SARS-CoV-2 virus, which is responsible for COVID-19. These spike proteins are essential for the virus to infect human cells.

Differences from Conventional Vaccines

Unlike traditional vaccines, which typically contain either pre-manufactured proteins or weakened pathogens to enhance the immune response, mRNA vaccines represent a novel approach to immunization.

The Importance of the Second Dose

Emergency Use Authorization

The rapid authorization of two mRNA vaccines within a year of the pandemic’s onset marks a significant milestone in vaccinology. As noted by Dr. Pulendran, a pathology professor at Stanford University School of Medicine, “this is the first time RNA vaccines have ever been given to humans.”

Research Findings on Immune Response

A study conducted by Stanford University researchers highlighted the critical role of the second vaccine dose in enhancing immune responses. The study analyzed a large number of blood samples from individuals vaccinated with the Pfizer vaccine. Researchers evaluated the complete gene expression of 242,479 distinct immune cell types, alongside antibody levels and immune-signaling proteins.

Should You Skip Your Second Dose?

Antibody Levels and Immune Response

The research team concluded that while the first dose of the COVID-19 vaccine does elevate antibody levels against SARS-CoV-2, the second dose significantly amplifies this response. Dr. Pulendran emphasized that “the second shot has powerful beneficial effects that far exceed those of the first shot… it stimulated a manifold increase in antibody levels, a terrific T-cell response that was absent after the first shot alone, and strikingly enhanced innate immune response.”

Impact on Monocyte Levels

Remarkably, the second dose was also found to mobilize and increase the count of a newly identified group of first-responder cells, known as monocytes, by 100 times in blood samples. This notable increase in monocytes, which is specifically linked to the second dose of the COVID-19 vaccine, reinforces the importance of completing the vaccination series.

References

Stanford Medicine. (2021, July 19). Study shows why second dose of COVID-19 vaccine shouldn’t be skipped. EurekAlert! https://www.eurekalert.org/pub_releases/2021-07/sm-ssw071921.php.
Polack, F.P., Thomas, S.J., Kitchin, N. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The New England Journal of Medicine (2020). https://doi.org/10.1056/NEJMoa2034577
Arunachalam, P.S., Scott, M.K.D., Hagan, T. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature (2021). https://doi.org/10.1038/s41586-021-03791-x
Image by Wilfried Pohnke from Pixabay.